Medical News

RSS

Political cartoon: 'Tax or Penalty?'

Kaiser Health News provides a fresh take on health policy developments with "Tax or Penalty?" by Bruce Tinsley.

23 Jul 2012

Positive results from BrainStorm's interim NurOwn stem cell therapy clinical trial for ALS

BrainStorm Cell Therapeutics announced today that it has completed the planned interim safety review of its Phase I/II ALS (Amyotrophic Lateral Sclerosis) clinical trial, indicating that autologous transplantation of the Company's cell therapy was well-tolerated, appears to be safe for use, and did not present any undue risks to the study participants.

23 Jul 2012

Low-lactose functional milk with ginseng may help improve cognitive function

American ginseng is reported to have neurocognitive effects, and research has shown benefits in aging, central nervous system disorders, and neurodegenerative diseases.

23 Jul 2012

Novel genomic sequencing method can help conduct in-depth analysis of single cells

Only by viewing a Georges Seurat painting at close range can you appreciate the hidden complexities of pointillism - small, distinct dots of color applied to form an image from a distance. Similarly, biologists and geneticists have long sought to analyze profiles of genes at the single cell level but technology limitations have only allowed a view from afar.

23 Jul 2012

Why it's hard for medicine to fix its mistakes

ProPublica offers an examination of the challenges hospitals face in adopting procedures to address medical errors.

23 Jul 2012

Alexza obtains $20 million flexible financing facility from Azimuth Opportunity

Alexza Pharmaceuticals, Inc. announced today that it has obtained a committed equity financing facility under which it may sell up to $20 million of its registered common stock to Azimuth Opportunity, L.P., over an approximately 24-month period.

23 Jul 2012

Reward-related decision making may be affected by the emotional processing system

Anxiety disorders affect approximately 40 million American adults each year, and although they are treatable, they often cause significant distress.

23 Jul 2012

New health professional roles emerge within the marketplace

This pair of stories from Kaiser Health News reports on new kinds of health professionals and the role they have within the health care continuum.

23 Jul 2012

Insights on neural mechanisms behind guidance of attention

Ever wonder how the human brain, which is constantly bombarded with millions of pieces of visual information, can filter out what's unimportant and focus on what's most useful?

23 Jul 2012

Cerulean commences dosing in CRLX101 Phase 2 study for ovarian cancer

Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 2 study of its lead candidate, CRLX101, in platinum-resistant ovarian cancer patients.

23 Jul 2012

SUMEC to distribute Aurora's breast MRI technology in China

Aurora Imaging Technology, Inc. is pleased to announce an exclusive China distribution agreement with the SUMEC Group Corporation.

23 Jul 2012

PTC Therapeutics completes $30M financing

PTC Therapeutics, Inc. (PTC) today announced the completion of a $30 million financing. The round included a number of long-term investors such as Credit Suisse First Boston Equity Partners, HBM BioVentures, Vulcan Ventures, Celgene, Delphi Ventures, The Column Group, Novo A/S, and other existing investors.

23 Jul 2012

Illumina sues IBS and Qiagen for infringement of three patents

Illumina, Inc. today announced that the company has sought leave to file counterclaims against Intelligent Bio-Systems, Inc. and Qiagen NV, which recently acquired IBS, in response to the patent lawsuit brought by Columbia University and IBS on March 26, 2012 in U.S. District Court in Wilmington, Delaware.

From Illumina, Inc. 23 Jul 2012

CBO's updated estimate of health law costs could be released this week

Meanwhile, news outlets report on varying aspects of the implementation of state-based health exchanges -- including the assistance provided to state officials by Michael O. Leavitt, an adviser to GOP presidential hopeful Mitt Romney and head of a health care consulting company.

23 Jul 2012

FDA meeting confirms Orexo regulatory submission of OX219 NDA on track

A meeting with the US regulatory agency FDA held on July 17 has confirmed that the Swedish pharmaceutical company Orexo is on track with its preparation for a regulatory submission of a new drug approval (NDA) for its medicine for treatment of opioid dependency, OX219.

23 Jul 2012

Protein associated with Huntington’s and other neurodegenerative diseases has several brain-specific forms

A protein essential for metabolism and recently associated with neurodegenerative diseases also occurs in several brain-specific forms. This discovery emerged in the course of a research project funded by the Austrian Science Fund FWF, the findings of which have now been published in the journal Human Molecular Genetics.

23 Jul 2012